What are the current ACIP vaccine recommendations for meningococcal?
The ACIP recommends routine administration of a MenACWY vaccine for all people ages 11-18. The recommended schedule consists of a single dose of MenACWY administered at 11 or 12 years followed by a booster dose at age 16.
What are the current recommendations for who should receive the meningococcal vaccine?
Routine Vaccination of Adolescents All 11 to 12 year olds should receive a meningococcal conjugate vaccine. Since protection wanes, CDC recommends a booster dose at age 16 years. The booster dose provides protection during the ages when adolescents are at highest risk of meningococcal disease.
Why is MenB vaccine not recommended?
ACIP does not recommend routine MenB vaccination for travel to countries in sub-Saharan Africa or to other countries for which MenACWY vaccine is recommended. Meningococcal disease in these areas is generally not caused by serogroup B….Related Tools:
How long does bexsero protection last?
The duration of protection following the recommended routine Bexsero® schedule has not been established, although in reviewing all of the available evidence, the JCVI agreed the most plausible duration of protection is 18 months following a two dose primary course and 36 months following the additional booster dose …
What age groups are recommended to receive bexsero and Trumenba?
What meningococcal vaccines are available in the United States?
|Trade Name||Type of Vaccine||Approved Ages|
|Menveo||Conjugate||2 mos.–55 years*|
|MenQuadfi||Conjugate||2 years and older|
What is the difference between meningitis and meningitis B vaccine?
The MenACWY vaccine is very effective at protecting against four strains of the bacteria, while the MenB vaccine protects against a fifth strain.
What age is bexsero for?
BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approved for use in individuals aged 10 through 25 years.
Should my baby get bexsero vaccine?
All infants and children aged <2 years are strongly recommended to receive MenB vaccine. Bexsero is the only MenB vaccine that can be used in infants and children aged <10 years. The number of doses required depends on the age of the child when they start the vaccine course. Medical conditions are specified in List.